660 related articles for article (PubMed ID: 11161602)
21. Tauroursodeoxycholic acid improves the survival and function of nigral transplants in a rat model of Parkinson's disease.
Duan WM; Rodrigues CM; Zhao LR; Steer CJ; Low WC
Cell Transplant; 2002; 11(3):195-205. PubMed ID: 12075985
[TBL] [Abstract][Full Text] [Related]
22. Astrocyte delivery of glial cell line-derived neurotrophic factor in a mouse model of Parkinson's disease.
Cunningham LA; Su C
Exp Neurol; 2002 Apr; 174(2):230-42. PubMed ID: 11922664
[TBL] [Abstract][Full Text] [Related]
23. Co-transplantation of carotid body and ventral mesencephalic cells as an alternative approach towards functional restoration in 6-hydroxydopamine-lesioned rats: implications for Parkinson's disease.
Shukla S; Agrawal AK; Chaturvedi RK; Seth K; Srivastava N; Sinha C; Shukla Y; Khanna VK; Seth PK
J Neurochem; 2004 Oct; 91(2):274-84. PubMed ID: 15447661
[TBL] [Abstract][Full Text] [Related]
24. Intrastriatal and intranigral grafting of hNT neurons in the 6-OHDA rat model of Parkinson's disease.
Baker KA; Hong M; Sadi D; Mendez I
Exp Neurol; 2000 Apr; 162(2):350-60. PubMed ID: 10739641
[TBL] [Abstract][Full Text] [Related]
25. Death of dopaminergic neurons in vitro and in nigral grafts: reevaluating the role of caspase activation.
Hurelbrink CB; Armstrong RJ; Luheshi LM; Dunnett SB; Rosser AE; Barker RA
Exp Neurol; 2001 Sep; 171(1):46-58. PubMed ID: 11520120
[TBL] [Abstract][Full Text] [Related]
26. Grafting of dopaminergic ventral mesencephalic slice cultures to the striatum of adult rats.
Sørensen JC; Ostergaard K; Zimmer J
Exp Neurol; 1994 Jun; 127(2):199-206. PubMed ID: 7913444
[TBL] [Abstract][Full Text] [Related]
27. Reformation of the nigrostriatal pathway by fetal dopaminergic micrografts into the substantia nigra is critically dependent on the age of the host.
Bentlage C; Nikkhah G; Cunningham MG; Björklund A
Exp Neurol; 1999 Sep; 159(1):177-90. PubMed ID: 10486186
[TBL] [Abstract][Full Text] [Related]
28. Nerve growth factor increases survival of dopaminergic graft, rescue nigral dopaminergic neurons and restores functional deficits in rat model of Parkinson's disease.
Chaturvedi RK; Shukla S; Seth K; Agrawal AK
Neurosci Lett; 2006 May; 398(1-2):44-9. PubMed ID: 16423459
[TBL] [Abstract][Full Text] [Related]
29. A model three-dimensional culture system for mammalian dopaminergic precursor cells: application for functional intracerebral transplantation.
Spector DH; Boss BD; Strecker RE
Exp Neurol; 1993 Dec; 124(2):253-64. PubMed ID: 7904568
[TBL] [Abstract][Full Text] [Related]
30. Walking pattern analysis after unilateral 6-OHDA lesion and transplantation of foetal dopaminergic progenitor cells in rats.
Klein A; Wessolleck J; Papazoglou A; Metz GA; Nikkhah G
Behav Brain Res; 2009 May; 199(2):317-25. PubMed ID: 19124044
[TBL] [Abstract][Full Text] [Related]
31. Exercise exerts neuroprotective effects on Parkinson's disease model of rats.
Tajiri N; Yasuhara T; Shingo T; Kondo A; Yuan W; Kadota T; Wang F; Baba T; Tayra JT; Morimoto T; Jing M; Kikuchi Y; Kuramoto S; Agari T; Miyoshi Y; Fujino H; Obata F; Takeda I; Furuta T; Date I
Brain Res; 2010 Jan; 1310():200-7. PubMed ID: 19900418
[TBL] [Abstract][Full Text] [Related]
32. Interference with anoikis-induced cell death of dopamine neurons: implications for augmenting embryonic graft survival in a rat model of Parkinson's disease.
Marchionini DM; Collier TJ; Camargo M; McGuire S; Pitzer M; Sortwell CE
J Comp Neurol; 2003 Sep; 464(2):172-9. PubMed ID: 12898610
[TBL] [Abstract][Full Text] [Related]
33. Co-transplantation of fetal lateral ganglionic eminence and ventral mesencephalon can augment function and development of intrastriatal transplants.
Costantini LC; Snyder-Keller A
Exp Neurol; 1997 May; 145(1):214-27. PubMed ID: 9184123
[TBL] [Abstract][Full Text] [Related]
34. A clonal line of mesencephalic progenitor cells converted to dopamine neurons by hematopoietic cytokines: a source of cells for transplantation in Parkinson's disease.
Carvey PM; Ling ZD; Sortwell CE; Pitzer MR; McGuire SO; Storch A; Collier TJ
Exp Neurol; 2001 Sep; 171(1):98-108. PubMed ID: 11520124
[TBL] [Abstract][Full Text] [Related]
35. Adjunctive use of the non-ionic surfactant Poloxamer 188 improves fetal dopaminergic cell survival and reinnervation in a neural transplantation strategy for Parkinson's disease.
Quinn M; Mukhida K; Sadi D; Hong M; Mendez I
Eur J Neurosci; 2008 Jan; 27(1):43-52. PubMed ID: 18093176
[TBL] [Abstract][Full Text] [Related]
36. Neurorescue effects of VEGF on a rat model of Parkinson's disease.
Yasuhara T; Shingo T; Muraoka K; Kameda M; Agari T; Wen Ji Y; Hayase H; Hamada H; Borlongan CV; Date I
Brain Res; 2005 Aug; 1053(1-2):10-8. PubMed ID: 16045899
[TBL] [Abstract][Full Text] [Related]
37. Amphetamine-induced abnormal movements occur independently of both transplant- and host-derived serotonin innervation following neural grafting in a rat model of Parkinson's disease.
Lane EL; Brundin P; Cenci MA
Neurobiol Dis; 2009 Jul; 35(1):42-51. PubMed ID: 19361557
[TBL] [Abstract][Full Text] [Related]
38. FK506 and cyclosporin A enhance the survival of cultured and grafted rat embryonic dopamine neurons.
Castilho RF; Hansson O; Brundin P
Exp Neurol; 2000 Jul; 164(1):94-101. PubMed ID: 10877919
[TBL] [Abstract][Full Text] [Related]
39. Differential dissection of the rat E16 ventral mesencephalon and survival and reinnervation of the 6-OHDA-lesioned striatum by a subset of aldehyde dehydrogenase-positive TH neurons.
Haque NS; LeBlanc CJ; Isacson O
Cell Transplant; 1997; 6(3):239-48. PubMed ID: 9171157
[TBL] [Abstract][Full Text] [Related]
40. The potential for circuit reconstruction by expanded neural precursor cells explored through porcine xenografts in a rat model of Parkinson's disease.
Armstrong RJ; Hurelbrink CB; Tyers P; Ratcliffe EL; Richards A; Dunnett SB; Rosser AE; Barker RA
Exp Neurol; 2002 May; 175(1):98-111. PubMed ID: 12009763
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]